Jude Children’s Research Hospital, USA, demonstrates benefits to using genomics and early treatment response to guide risk classification of...
Vous n'êtes pas connecté
L-Asparaginase is an enzyme that has revolutionized the treatment of certain types of cancer, particularly acute lymphoblastic leukemia (ALL). This enzyme catalyzes the hydrolysis of asparagine, an amino acid, into aspartic acid and ammonia. By depleting asparagine, L-asparaginase starves cancer cells that depend on this amino acid for survival and proliferation. Its unique mechanism has made it a cornerstone in the chemotherapy regimens for ALL.
Jude Children’s Research Hospital, USA, demonstrates benefits to using genomics and early treatment response to guide risk classification of...
TUESDAY, Sept. 24, 2024 -- For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first...
The Princess, who recently completed chemotherapy treatment following her own cancer diagnosis, met Liz Hatton, who has a rare and aggressive form of...
Kate, the Princess of Wales, made her first public appearance Sunday since she announced she had completed chemotherapy and would return to some...
MONDAY, Sept. 23, 2024 -- All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom,...
A study based on clinical trial data found higher risks of stroke, heart attack, and hospital admission for heart failure in older cancer survivors....
Frequent fevers in children may signal leukemia, warns Dr. Dhiman. Early detection is vital for treatment. A new playroom aids young patients'...